Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid on PANC-1 and AsPC-1 Human Pancreas Tumor Cells
Journal: 2020/July - Cancer
Abstract:
Purpose: New tetrahydrocannabinolic acid (THCA) derivatives ALAM027 and ALAM108 were proposed for the treatment of the pancreatic cancer disease. Methods: The in vitro effect of new cannabinoids ALAM027 and ALAM108 was tested against PANC-1 and AsPC-1 cell lines by CellTiter Glo assay. Pancreatic cancer xenograft model was used for the in vivo anticancer activity study of these compounds on PANC-1 cells. Results: The in vitro study of new cannabinoids showed greater activity of ALAM108 than ALAM027 both for PANC-1 and AsPC-1 cells. The in vivo study of new cannabinoids on PANC-1 cells showed that their oral administration was effective in reducing tumor volume and tumor weight, and did not lead to any discomfort and weight loss of mice. Conclusion: The cannabinoids ALAM108 and ALAM027 inhibited the tumor growing 1.6-2 times in mice with human PANC-1 cells.
Keywords: AsPC-1; PANC-1; THCA; cannabinoids; in vitro; in vivo.
Relations:
Content
References
(8)
Diseases
(1)
Conditions
(1)
Chemicals
(1)
Anatomy
(3)
Similar articles
Articles by the same authors
Discussion board
J Pancreat Cancer 6(1): 40-44

Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid on PANC-1 and AsPC-1 Human Pancreas Tumor Cells

AL&AM Pharmachem Ltd., Rehovot, Israel.
Address correspondence to: Alexander Aizikovich, PhD, AL&AM Pharmachem Ltd., Carmel st. 5/35, Rehovot 76305, Israel moc.liamg@35kiziaxela
Accepted Accepted May 19, 2020.
This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose: New tetrahydrocannabinolic acid (THCA) derivatives ALAM027 and ALAM108 were proposed for the treatment of the pancreatic cancer disease.

Methods: The in vitro effect of new cannabinoids ALAM027 and ALAM108 was tested against PANC-1 and AsPC-1 cell lines by CellTiter Glo assay. Pancreatic cancer xenograft model was used for the in vivo anticancer activity study of these compounds on PANC-1 cells.

Results: The in vitro study of new cannabinoids showed greater activity of ALAM108 than ALAM027 both for PANC-1 and AsPC-1 cells. The in vivo study of new cannabinoids on PANC-1 cells showed that their oral administration was effective in reducing tumor volume and tumor weight, and did not lead to any discomfort and weight loss of mice.

Conclusion: The cannabinoids ALAM108 and ALAM027 inhibited the tumor growing 1.6–2 times in mice with human PANC-1 cells.

Keywords: AsPC-1, cannabinoids, in vitro, in vivo, PANC-1, THCA

Acknowledgments

The author thanks the employees of Shanghai Chempartner (China) and Pharmaseed Ltd. (Israel) for their high professionalism and attention in this study.

Abbreviations Used

GCgemcitabine
NPTnab-paclitaxel
RTroom temperature
THCtetrahydrocannabinol
THCAtetrahydrocannabinolic acid

References

  • 1. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921 [[PubMed][Google Scholar]
  • 2. Cridge BJ, Rosengren RJ Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manage Res. 2013;5:301–313 [Google Scholar]
  • 3. Dariš B, Tancer Verboten M, Željko Knez, et al. Cannabinoids in cancer treatment: therapeutic potential and legislation. Bosn J Basic Med Sci. 2019;19:14–23 [Google Scholar]
  • 4. Sharafi G, He H, Nikfarjam M Potential use of cannabinoids for the treatment of pancreatic cancer. J Pancreatic Cancer. 2019;5:1–7 [Google Scholar]
  • 5. Velasco G, Sánchez C, Guzmán M Towards the use of cannabinoids as antitumor agents. Nat Rev Cancer. 2012;12:436–444 [[PubMed][Google Scholar]
  • 6. Carridero A, Gironella M, Lorente M, et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 2006; 66:6748–6765 [[PubMed][Google Scholar]
  • 7. Aizikovich A. Cannabinolic acid derivatives and uses thereof. WO2019234728
  • 8. Aizikovich A. Process for purification of cannabinoid acids from plant material extract. WO2020016875
  • 9. Awasthi N, Zhang C, Schwarz AM, et al. Comparative benefits of nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. Carcinogenesis. 2013;34:2361–2369 [Google Scholar]
  • 10. Awasthi N, Monahan S, Stefaniak A, et al. Inhibition of the MEK/ERK pathway augments nab-paclitaxel based chemotherapy effects in preclinical models of pancreatic cancer. Oncotarget. 2018;9:5274–5286 [Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.